← FDA DRUG APPROVALS

FDA NDA · NDA005151

PERCORTEN

Sponsor: NOVARTIS

APPLICATION
NDA005151
TYPE
NDA
ORIGINAL APPROVAL
1942-12-09
LATEST ACTION
1997-06-25
ROUTE
IMPLANTATION
DOSAGE FORM
PELLET
MARKETING STATUS
Discontinued

Products

PERCORTENDiscontinued
DESOXYCORTICOSTERONE ACETATE 125MG · PELLET · IMPLANTATION

Approval history

1997-06-25Labeling · Supplement 3AP
1983-10-13Labeling · Supplement 6AP
1983-05-16Labeling · Supplement 5AP
1942-12-09UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →